Apollo Hospitals Enterprise Limited vs Thyrocare Technologies Limited

A side-by-side comparison of Apollo Hospitals Enterprise Limited (APOLLOHOSP) and Thyrocare Technologies Limited (THYROCARE) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Thyrocare Technologies Limited leads APOLLOHOSP vs THYROCARE on 9 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability04
  • Growth02
  • Size & financial health31
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

58.43
P/E ratio
47.27
13.46
P/B ratio
17.30
0.22%
Dividend yield
2.51%
₹135.04
EPS
₹10.27

Profitability

THYROCARE takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

20.48%
Return on equity
27.85%
17.31%
Return on capital
33.90%
14.94%
EBITDA margin
31.61%
7.94%
Net margin
19.64%

Growth

THYROCARE takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
16.30%
33.35%
Profit CAGR (3Y)
36.52%

Size & financial health

APOLLOHOSP takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.14L Cr
Market cap
₹7,737 Cr
₹25,229 Cr
Revenue
₹829 Cr
₹2,003 Cr
Net profit
₹163 Cr
0.90
Debt / equity
0.09
Apollo Hospitals Enterprise Limited
  • + ["Company has delivered good profit growth of 71.1% CAGR over last 5 years", "Company has delivered good sales growth of 19.0% CAGR over last 5 years"]
  • − ["Stock is trading at 11.98 times its book value"]
Thyrocare Technologies Limited
  • + ["Company has been maintaining a healthy dividend payout of 136.8%", "Company is almost debt free."]
  • − ["Stock is trading at 13.21 times its book value"]
Apollo Hospitals Enterprise Limited full analysis Thyrocare Technologies Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.